Dosing of rapamycin is critical to achieve an optimal antiangiogenic effect against cancer
Dosing of rapamycin is critical to achieve an optimal antiangiogenic effect against cancer is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Dosing of rapamycin is critical to achieve an optimal antiangiogenic effect against cancer have?
Dosing of rapamycin is critical to achieve an optimal antiangiogenic effect against cancer has 93 citations in the OpenAlex counts ScholarIQ stores.
When was Dosing of rapamycin is critical to achieve an optimal antiangiogenic effect against cancer published?
Dosing of rapamycin is critical to achieve an optimal antiangiogenic effect against cancer has 2004 year in the ScholarIQ index.
What is the open-access status of Dosing of rapamycin is critical to achieve an optimal antiangiogenic effect against cancer?
Dosing of rapamycin is critical to achieve an optimal antiangiogenic effect against cancer has closed oa status in the ScholarIQ index.
What is the DOI of Dosing of rapamycin is critical to achieve an optimal antiangiogenic effect against cancer?
The DOI for Dosing of rapamycin is critical to achieve an optimal antiangiogenic effect against cancer is on the source record.
What is the PMID of Dosing of rapamycin is critical to achieve an optimal antiangiogenic effect against cancer?
The PMID for Dosing of rapamycin is critical to achieve an optimal antiangiogenic effect against cancer is on the source record.
What is the OpenAlex record for Dosing of rapamycin is critical to achieve an optimal antiangiogenic effect against cancer?
The OpenAlex for Dosing of rapamycin is critical to achieve an optimal antiangiogenic effect against cancer is on the source record.